Author

Eirini Kasa

The Netherlands Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Ben MorrisiD· 1 shared Camiel GöbeliD· 1 shared Daan J. KloostermaniD· 1 shared Daniël de Groot· 1 shared Fred van LeeuweniD· 1 shared Heinz JacobsiD· 1 shared Jayashree JayachandraniD· 1 shared Ji‐Ying SongiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ben MorrisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B Cell Lymphoma

Camiel Göbel, Rachele Niccolai, Marnix H. P. de Groot, Jayashree Jayachandran, Joleen J.H. Traets, Daan J. Kloosterman, Sebastian Gregoricchio, Ben Morris, Maaike Kreft, Ji‐Ying Song, Leyla Azarang, Eirini Kasa, Nienke Oskam, Daniël de Groot, Liesbeth Hoekman, , Heinz Jacobs

This study shows that targeting DOT1L and EZH2 together disrupts the germinal center identity of GCB-DLBCL cells, leading to a cell-identity crisis and reduced tumor growth in vivo.

Blood · Jan 10, 2025Peer-reviewedCancer Biology